Sanofi-Aventis 3Q Profit Rises 9 Pct - Forbes

Sanofi-Aventis 3Q Profit Rises 9 Pct
Forbes, NY -4 hours ago
In June, Sanofi-Aventis pulled its application for market approval of Acomplia in the United States, where it is known as Zimulti, after a Food and Drug …

More: continued here